Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-057490

President & CEO sold 13,556 shares at $17.97 ($243,601)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2019-11-18 Sale −13,556 $17.97 $243,601 299,219 D: show line 1 in the form
Open-market sales · 13,556 sh · avg $17.97 · $243,601
Loading xslF345X03/doc4.xml…